Unlike current therapies that target one or two pathways, retatrutide acts on: GLP-1 receptor GIP receptor Glucagon receptor This multi-target approach aims to improve weight loss while also enhancing metabolic health
Health Conditions A-Z Health & Wellness Nutrition Fitness Health News Ayurveda Videos Medicine A-Z Parenting Login to get the latest articles, videos, gallery, and a lot more or continue with Email Google Facebook To get Registered Signup now Credit: Canva Riya Baibhawi Updated Apr 20, 2025 | 09:19 PM IST Summary Lilly, known for injectable drugs like Zepbound for obesity and Mounjaro and Trulicity for diabetes, is among several pharmaceutical companies racing to develop a pill form of GLP-1 medication
ACSL4 and LPCAT3 serve as central lipid metabolic regulators of ferroptosis, yet their functions appear to be disease and context dependent
Medical interventions like bariatric surgery and GLP-1 medications such as Ozempic can reduce food noise
Additionally, for patients with acquired hypothalamic obesity due to hypothalamic injury (such as craniopharyngioma and its treatment), where the pathogenesis is complex and GLP-1 therapy offers limited benefits, no approved drugs are currently available
Tumor spheroid formation assay K1 thyroid cancer cells (1 10 4 ) were seeded into a 96-well ultra-low-binding plate in organoid-specific media